Acute Leukemia
Conditions
Keywords
Health related quality of life
Brief summary
The purpose of this study is to evaluate the impact of an exercise intervention on patient-reported anxiety, depression, fatigue, and sleep disturbances among acute leukemia patients. The investigators hypothesize that exercise will reduce fatigue in acute leukemia patients.
Detailed description
The purpose of this randomized, prospective, longitudinal study is to evaluate the impact of an exercise intervention on patient-reported anxiety, depression, fatigue, and sleep disturbances outcomes among acute leukemia patients. The study will include 2 groups for a total sample size of 30: n=15 control group and n=15 intervention group. Each patient enrolled in the intervention arm will participate in an exercise program for the duration of their hospitalization, 4-6 weeks on average during the first treatment (induction chemotherapy).
Interventions
OTHERExercise
All intervention patients will participate in an individualized prescriptive exercise intervention 2 to 4 times per week for a period of the induction chemotherapy/in-hospital recovery. The exercise intervention will begin on week 1 of the study, the day after the first batteries of initial assessments are concluded. Each exercise session will be divided into two parts. One part will be administered in the morning and the second one late in the afternoon. There will be a period of rest of at least 36 hours between each exercise session.
Sponsors
UNC Lineberger Comprehensive Cancer Center
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
21 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Newly diagnosed with acute leukemia by pathology report * Admitted for induction chemotherapy within in the previous 96 hours or +/- 3 days from initiation of induction chemotherapy * An expected hospital stay of 3-4 weeks or longer * Participation in the study must be approved by the physician directly responsible for the patient's care while at University of North Carolina -Hospitals * Age \>21 years of age * Willing and able to provide, signed informed consent * Willing and able to use a computer to complete study questionnaires * Ability to understand and speak English
Exclusion criteria
The criteria below will be determined by the patient's physician and a review of the patient's medical history. If any of the
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Compare symptoms of fatigue in newly diagnosed acute leukemia patients | participants will be followed for the duration of hospital stay, an expected average of 6 weeks | Symptoms will be assessed by patient reported survey at baseline, weekly through patient hospitalization, and then again at patient's first appointment after hospital discharge. We are interested in how the symptom changes over time. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Compare symptoms of anxiety between groups | participants will be followed for the duration of hospital stay, an expected average of 6 weeks | Symptoms will be assessed by patient reported survey at baseline, weekly during hospitalization, and at first clinic visit after discharge from hospital. We are interested in change over time between groups. |
| Compare symptoms of depression between groups | participants will be followed for the duration of hospital stay, an expected average of 6 weeks | Symptoms will be assessed by patient reported survey at baseline, weekly during hospitalization, and at first clinic visit after discharge from hospital. We are interested in change over time between groups. |
| Compare sleep quality between groups | participants will be followed for the duration of hospital stay, an expected average of 6 weeks | Symptoms will be assessed by patient reported survey at baseline, weekly during hospitalization, and at first clinic visit after discharge from hospital. We are interested in change over time between groups. |
| Changes in cardiovascular function | participants will be followed for the duration of hospital stay, an expected average of 6 weeks | Exercise testing which will assess the outcome measures will be performed at baseline, and after 4 weeks of training (for the intervention group), or at the week 4 time point (for the control group). We are interested in change over time between groups. |
| Evaluate health-related quality of life changes over time | participants will be followed for the duration of hospital stay, an expected average of 6 weeks | Health related quality of life will be assessed by patient reported survey at baseline, and at the week 4 timepoint. We are interested in change over time between groups |
| Changes in body composition | participants will be followed for the duration of hospital stay, an expected average of 6 weeks | Exercise testing which will assess the outcome measures will be performed at baseline, and after 4 weeks of training (for the intervention group), or at the week 4 time point (for the control group). We are interested in change over time between groups. |
| Changes in functional mobility | participants will be followed for the duration of hospital stay, an expected average of 6 weeks | Exercise testing which will assess the outcome measures will be performed at baseline, and after 4 weeks of training (for the intervention group), or at the week 4 time point (for the control group). We are interested in change over time between groups. |
| Changes in muscle size | participants will be followed for the duration of hospital stay, an expected average of 6 weeks | Exercise testing which will assess the outcome measures will be performed at baseline, and after 4 weeks of training (for the intervention group), or at the week 4 time point (for the control group). We are interested in change over time between groups. |
| Changes in muscle strength | participants will be followed for the duration of hospital stay, an expected average of 6 weeks | Exercise testing which will assess the outcome measures will be performed at baseline, and after 4 weeks of training (for the intervention group), or at the week 4 time point (for the control group). We are interested in change over time between groups. |
Countries
United States
Outcome results
None listed